Generics - Diabetes, Patents

Filter

Current filters:

DiabetesPatents

Popular Filters

Intas Pharma settles with Roche over Xeloda; Merck & Co wins injunction against Aprica

25-06-2013

Indian drugmaker Intas Pharmaceuticals and its wholly owned subsidiary Accord Healthcare have entered…

Aprica PharmaceuticalsAsia-PacificDiabetesGenericsIntas PharmaceuticalsMerck & CoNorth AmericaOncologyPatentsRocheXeloda

Negative US patent ruling for Novo Nordisk on Prandin

19-06-2013

Denmark-based insulin giant Novo Nordisk (NOV: N) says that the US Court of Appeals for the Federal Circuit…

DiabetesGenericsLegalNovo NordiskPatentsPharmaceuticalPrandin

Mylan confirms Actoplus patent challenge

09-01-2012

US generic drugmaker Mylan (Nasdaq: MYL) has confirmed that it has been sued by Takeda Pharmaceutical…

AndrxDiabetesGenericsLegalMylan LaboratoriesNorth AmericaPatentsTakeda PharmaceuticalsWatson Pharmaceuticals

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top